Reinforcement of the Standard Therapy with Two Infusions of Convalescent Plasma for Patients with COVID-19: A Randomized Clinical Trial

Background: The aim was to evaluate the reinforcement of the standard therapy with hyperimmune plasma (HP) in Coronavirus-19 disease (COVID-19) patients. Methods: Open-label, multicenter, randomized clinical trial performed in three hospitals in the Balearic Islands. Non-severe COVID-19 hospitalized...

Descripción completa

Detalles Bibliográficos
Autores principales: Bargay-Lleonart, Joan, Sarubbo, Fiorella, Arrizabalaga, Maria, Guerra, José Maria, Borràs, Josep, El Haji, Khaoulah, Flexas, Magdalena, Perales, Jorge, Fernández-Baca, Victoria, Gallegos, Carmen, Cruz, Manuel Raya, Velasco, Sonia, López, Víctor, Cruz, Ana, Bautista-Gili, Antonia, Jimenez-Marco, Teresa, Girona-Llobera, Enric, Vilaplana, Laia, Calonge, Laura, Tena, Juan, Galán, Maria Pilar, Payeras, Antoni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181298/
https://www.ncbi.nlm.nih.gov/pubmed/35683427
http://dx.doi.org/10.3390/jcm11113039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181298/
https://www.ncbi.nlm.nih.gov/pubmed/35683427
http://dx.doi.org/10.3390/jcm11113039

Ejemplares similares